What is Unicycive Therapeutics Total Payout Yield %?
Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.
Unicycive Therapeutics Total Payout Yield % Historical Data
The historical data trend for Unicycive Therapeutics's Total Payout Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Unicycive Therapeutics's Total Payout Yield %
For the Biotechnology subindustry, Unicycive Therapeutics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unicycive Therapeutics's Total Payout Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Unicycive Therapeutics's Total Payout Yield % distribution charts can be found below:
* The bar in red indicates where Unicycive Therapeutics's Total Payout Yield % falls into.
Unicycive Therapeutics Total Payout Yield % Calculation
Total Payout Yield % is a measure of shareholder return.
Unicycive Therapeutics's Total Payout Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unicycive Therapeutics Total Payout Yield % Explanation
Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.
Unicycive Therapeutics Total Payout Yield % Related Terms
Thank you for viewing the detailed overview of Unicycive Therapeutics's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Unicycive Therapeutics (Unicycive Therapeutics) Business Description
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UNCY has been successfully added to your 